India  
 
NewsR.in

Covaxin neutralises UK strain: Biotech

IndiaTimes Thursday, 28 January 2021
0
shares		ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

BBV152 BBV152 Vaccine against COVID-19

Use entire national capacity to step up Covid vaccine production, PM tells officials

 The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
IndiaTimes

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

 Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

India to increase Covaxin production to 100 million doses per month by September

 The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

Related videos from verified sources

'Fresh infection wave in China, Europe...': Doctors on Covid vaccine doubts [Video]

'Fresh infection wave in China, Europe...': Doctors on Covid vaccine doubts

Even as India launched its Covid-19 immunisation drive on January 16, some sections continue to raise doubts. Dr Anil Dhar and Dr Atul Peters of Max hospital, and Dr Suranjit Chatterjee of Apollo..

Credit: HT Digital Content     Duration: 04:26Published
First feeling, side-effects, doubts: Vaccinated doctors share experience [Video]

First feeling, side-effects, doubts: Vaccinated doctors share experience

On Day 1 of India's Covid-19 vaccination, two doctors who took the shots shared their experience. Dr Atul Peters and Anil Dhar of Max hospital were given Bharat Biotech's Covaxin and SII-made..

Credit: HT Digital Content     Duration: 08:15Published
Covid vaccine: Meet AIIMS sanitation worker who volunteered to be 1st recipient [Video]

Covid vaccine: Meet AIIMS sanitation worker who volunteered to be 1st recipient

With India's Covid immunisation drive launching on January 16, a sanitation worker became the first vaccine recipient at the country's premier AIIMS hospital in Delhi. Manish Kumar said that seeing..

Credit: HT Digital Content     Duration: 03:49Published

Related news from verified sources

Covaxin generated excellent safety data, says Bharat Biotech

 Amid the criticism of the Drug Controller General of India (DCGI) for granting approval for emergency use of Covid-19 vaccine Covaxin, its manufacturer Bharat...
Mid-Day Also reported by •IndiaTimes

Bharat Biotech gets permission to manufacture Covaxin for sale

 The Central Licensing Authority on Sunday granted permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution, after the...
Mid-Day Also reported by •IndiaTimes •Hindu •DNA

'Covaxin is 200% safe': Bharat Biotech MD says Covaxin 'being targeted for being Indian company's product'

 Bharat Biotech MD Krishna Ella on Tuesday refuted criticism surrounding his company's coronavirus vaccine saying that Covaxin is "200% safe" and it is being...
IndiaTimes